Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France Naas T; Coignard B; Carbonne A; Blanckaert K; Bajolet O; Bernet C; Verdeil X; Astagneau P; Desenclos JC; Nordmann PEmerg Infect Dis 2006[Aug]; 12 (8): 1214-22VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii was responsible for an outbreak in hospitals in France. A national alert was triggered in September 2003 when 4 hospitals reported clusters of A. baumannii infection with similar susceptibility profiles. Case definitions and laboratory guidelines were disseminated, and prospective surveillance was implemented; strains were sent to a single laboratory for characterization and typing. From April 2003 through June 2004, 53 hospitals reported 290 cases of A. baumannii infection or colonization; 275 isolates were bla(VEB-1)-positive and clonally related. Cases were first reported in 5 districts of northern France, then in 10 other districts in 4 regions. Within a region, interhospital spread was associated with patient transfer. In northern France, investigation and control measures led to a reduction of reported cases after January 2004. The national alert enabled early control of new clusters, demonstrating the usefulness of early warning about antimicrobial drug resist.|*Disease Outbreaks[MESH]|*beta-Lactam Resistance[MESH]|Acinetobacter Infections/*epidemiology/microbiology[MESH]|Acinetobacter baumannii/classification/*drug effects/enzymology/genetics[MESH]|Cross Infection/*epidemiology/microbiology[MESH]|Escherichia coli Proteins[MESH]|France/epidemiology[MESH]|Hospitals[MESH]|Humans[MESH]|Infection Control/methods[MESH]|Microbial Sensitivity Tests[MESH]|Population Surveillance[MESH]|beta-Lactamases/*metabolism[MESH] |
